Clinical Trials Directory

Trials / Completed

CompletedNCT05515198

Improving Care for Women With Urinary Incontinence (EMPOWER)

Empowering Women and Providers for Improved Care of Urinary Incontinence (UI) [EMPOWER Study]

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
400 (actual)
Sponsor
University Hospitals Cleveland Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overall goal is to improve diagnosis and non-operative management of urinary incontinence in women.

Detailed description

In the study, patients will be screened in primary care offices for symptoms of urinary incontinence. Women with positive screening results will be asked if they are interested in participating in an implementation study where women will be assigned to one of the three following groups: 1. Usual Care plus Patient Educational Opportunities - The patient's urinary incontinence will be managed using standard of care treatment by the patient's primary care provider. Patients will be offered educational opportunities about urinary incontinence. 2. Nurse Navigation - Along with the treatment described for "Usual Care plus Patient Educational Opportunities," a nurse navigator will work with the patient to implement behavioral changes and provide education and physical therapy options. In addition, the navigator will be available to answer the patient's questions in a timely fashion and help the patient move through the care pathway. 3. Nurse Navigation and ChatBot - Along with the treatment described for "Usual Care plus Patient Educational Opportunities" and "Nurse Navigation," this group will include a ChatBot feature which will allow a patient to directly and privately communicate with an artificial intelligence-driven ChatBot, also known as a "conversational agent," that will provide education and help the patient navigate the care pathway. All participants will complete questionnaires throughout their enrollment and data will be collected from medical records. The study team will analyze the data at six months after the original appointment/study enrollment, assess adherence to therapy and how the therapy impacted the outcomes the team hopes to improve, such as improvement in symptoms. The study will be implemented over three subsequent time periods called Wave 1, Wave 2 and Wave 3 with primary care practices from two geographic regions being involved in each wave (6 regions total). Participants in Wave 1 will be followed for a total of 18 months, while participants in Wave 2 will be followed for a total of 12 months, and participants in Wave 3 will be followed for 6 months. Primary care providers at all participating practices will be offered educational opportunities related to urinary incontinence.

Conditions

Interventions

TypeNameDescription
OTHERPatient EducationPatients will be provided educational opportunities.
OTHERNurse NavigationA nurse navigator will work with the participants to help them navigate the care pathway. The navigator will provide education and recommendations for treatment options.
OTHERChatBotA ChatBot will allow participants to directly and privately communicate through a smartphone (or other device) with an artificial intelligence-driven ChatBot, also known as a "conversational agent," that will provide education and encouragement to manage their symptoms.

Timeline

Start date
2022-09-06
Primary completion
2024-12-23
Completion
2024-12-23
First posted
2022-08-25
Last updated
2025-02-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05515198. Inclusion in this directory is not an endorsement.